These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Nuclear signalling by tumour-associated antigen EpCAM. Maetzel D; Denzel S; Mack B; Canis M; Went P; Benk M; Kieu C; Papior P; Baeuerle PA; Munz M; Gires O Nat Cell Biol; 2009 Feb; 11(2):162-71. PubMed ID: 19136966 [TBL] [Abstract][Full Text] [Related]
3. The role of nuclear EpICD in extrahepatic cholangiocarcinoma: association with β-catenin. Jachin S; Bae JS; Sung JJ; Park HS; Jang KY; Chung MJ; Kim DG; Moon WS Int J Oncol; 2014 Aug; 45(2):691-8. PubMed ID: 24888903 [TBL] [Abstract][Full Text] [Related]
4. Members of the EpCAM signalling pathway are expressed in gastric cancer tissue and are correlated with patient prognosis. Warneke VS; Behrens HM; Haag J; Krüger S; Simon E; Mathiak M; Ebert MP; Röcken C Br J Cancer; 2013 Oct; 109(8):2217-27. PubMed ID: 24008668 [TBL] [Abstract][Full Text] [Related]
5. Functional Implications of the Dynamic Regulation of EpCAM during Epithelial-to-Mesenchymal Transition. Brown TC; Sankpal NV; Gillanders WE Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209658 [TBL] [Abstract][Full Text] [Related]
7. MMP7 is a target of the tumour-associated antigen EpCAM. Denzel S; Mack B; Eggert C; Massoner P; Stöcklein N; Kemming D; Harréus U; Gires O Int J Exp Pathol; 2012 Oct; 93(5):341-53. PubMed ID: 22974215 [TBL] [Abstract][Full Text] [Related]
8. Nuclear EpICD expression and its role in hepatocellular carcinoma. Park SY; Bae JS; Cha EJ; Chu HH; Sohn JS; Moon WS Oncol Rep; 2016 Jul; 36(1):197-204. PubMed ID: 27176150 [TBL] [Abstract][Full Text] [Related]
9. Loss of membranous expression of the intracellular domain of EpCAM is a frequent event and predicts poor survival in patients with pancreatic cancer. Fong D; Moser P; Kasal A; Seeber A; Gastl G; Martowicz A; Wurm M; Mian C; Obrist P; Mazzoleni G; Spizzo G Histopathology; 2014 Apr; 64(5):683-92. PubMed ID: 24117877 [TBL] [Abstract][Full Text] [Related]
11. Intracellular domain of epithelial cell adhesion molecule induces Wnt receptor transcription to promote colorectal cancer progression. Panda SS; Lee CC; Geevimaan K; Chen KC; Yang SH; Shen CN; HuangFu WC; Wu HC J Biomed Sci; 2024 Jul; 31(1):72. PubMed ID: 39010070 [TBL] [Abstract][Full Text] [Related]
12. Extracellular domain of EpCAM enhances tumor progression through EGFR signaling in colon cancer cells. Liang KH; Tso HC; Hung SH; Kuan II; Lai JK; Ke FY; Chuang YT; Liu IJ; Wang YP; Chen RH; Wu HC Cancer Lett; 2018 Oct; 433():165-175. PubMed ID: 29981429 [TBL] [Abstract][Full Text] [Related]
13. Expression of EpCAM(MF) and EpCAM(MT) variants in human carcinomas. Fong D; Seeber A; Terracciano L; Kasal A; Mazzoleni G; Lehne F; Gastl G; Spizzo G J Clin Pathol; 2014 May; 67(5):408-14. PubMed ID: 24465008 [TBL] [Abstract][Full Text] [Related]
14. EpCAM: another surface-to-nucleus missile. Carpenter G; Red Brewer M Cancer Cell; 2009 Mar; 15(3):165-6. PubMed ID: 19249674 [TBL] [Abstract][Full Text] [Related]
15. A high-content screen for small-molecule regulators of epithelial cell-adhesion molecule (EpCAM) cleavage yields a robust inhibitor. Tretter JY; Schorpp K; Luxenburger E; Trambauer J; Steiner H; Hadian K; Gires O; Niessing D J Biol Chem; 2018 Jun; 293(23):8994-9005. PubMed ID: 29700109 [TBL] [Abstract][Full Text] [Related]
16. Membrane-associated epithelial cell adhesion molecule is slowly cleaved by γ-secretase prior to efficient proteasomal degradation of its intracellular domain. Huang Y; Chanou A; Kranz G; Pan M; Kohlbauer V; Ettinger A; Gires O J Biol Chem; 2019 Mar; 294(9):3051-3064. PubMed ID: 30598504 [TBL] [Abstract][Full Text] [Related]
17. Epithelial cell adhesion molecule (EpCAM) complex proteins promote transcription factor-mediated pluripotency reprogramming. Huang HP; Chen PH; Yu CY; Chuang CY; Stone L; Hsiao WC; Li CL; Tsai SC; Chen KY; Chen HF; Ho HN; Kuo HC J Biol Chem; 2011 Sep; 286(38):33520-32. PubMed ID: 21799003 [TBL] [Abstract][Full Text] [Related]
18. EpEX, the soluble extracellular domain of EpCAM, resists cetuximab treatment of EGFR-high head and neck squamous cell carcinoma. Umemori K; Ono K; Eguchi T; Kawai H; Nakamura T; Ogawa T; Yoshida K; Kanemoto H; Sato K; Obata K; Ryumon S; Yutori H; Katase N; Okui T; Nagatsuka H; Ibaragi S Oral Oncol; 2023 Jul; 142():106433. PubMed ID: 37236125 [TBL] [Abstract][Full Text] [Related]
19. EpCAM and the biology of hepatic stem/progenitor cells. Dollé L; Theise ND; Schmelzer E; Boulter L; Gires O; van Grunsven LA Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(4):G233-50. PubMed ID: 25477371 [TBL] [Abstract][Full Text] [Related]
20. Glycosylation is crucial for stability of tumour and cancer stem cell antigen EpCAM. Munz M; Fellinger K; Hofmann T; Schmitt B; Gires O Front Biosci; 2008 May; 13():5195-201. PubMed ID: 18508581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]